Lupus Clinical Trials 2024

Lupus Clinical Trials 2024

Lupus research studies recruiting patients in 2024 need your help. Receive premium care & cutting edge treatments by enrolling in lupus clinical trials today.

Lupus Clinical Trials

Here are the 6 most popular medical studies for lupus

Popular filter options for lupus trials

Anti-dsDNA Positive Clinical Trials

View 12 anti-dsDNA positive medical studies.

Phase 3 Lupus Clinical Trials

View 91 phase 3 lupus medical studies.

Lupus Clinical Trials With No Placebo

View 91 lupus medical studies that do not have a placebo group.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Introduction to lupus

What are the top hospitals conducting lupus research?

Lupus, an autoimmune disease that affects millions of people worldwide, has sparked a surge in clinical trials aimed at finding new treatments and interventions. In Oklahoma City, the Oklahoma Medical Research Foundation leads the charge with seven ongoing lupus trials. This innovative facility is dedicated to unraveling the mysteries of this complex condition and paving the way for improved management options. SUNY Upstate Medical University in Syracuse also plays a vital role in lupus research, currently conducting six active clinical trials. Researchers here are committed to discovering breakthroughs that can alleviate the burden of this chronic illness on patients' lives.

In Dallas, the Metroplex Clinical Research Center is actively involved in five lupus trials, striving to uncover better ways to diagnose and treat this challenging condition. Meanwhile, at the Medical University of South carolina in Charleston, researchers are working diligently on five ongoing clinical studies focused on lupus intervention and management strategies.

Finally, NYU Langone Health joins these esteemed institutions with four active lupus trials taking place within its walls. Located in New york City—a hub for medical innovation—NYU Langone Health is part of a vibrant community committed to advancing our understanding of autoimmune diseases like lupus.

These hospitals stand as beacons of hope for individuals living with lupus across the United States and beyond. Through their dedication and tireless efforts, they strive not only to improve treatment options but also offer promising avenues towards a future where individuals affected by this debilitating disease can lead fuller lives.

Which are the best cities for lupus clinical trials?

When it comes to lupus clinical trials, several cities emerge as leaders in research and innovation. New york City boasts 33 active trials, focusing on treatments like Hydroxychloroquine (HCQ), Deucravacitinib, and CC-97540 administration. Miami, Florida follows closely with 29 ongoing studies exploring Nipocalimab, ALPN-101, and GLPG3667 as potential therapies. Houston, Texas is also a hub for lupus clinical trials with 25 active studies investigating treatments such as ALPN-101 and Cenerimod. These cities offer individuals living with lupus access to cutting-edge research that may lead to improved outcomes and better management of this autoimmune disease.

Which are the top treatments for lupus being explored in clinical trials?

Lupus, a complex autoimmune disease, is being targeted by several noteworthy treatments currently undergoing clinical trials. At the forefront of research is belimumab, an established medication that has shown promising results and continues to be explored in ongoing studies. Another contender is baricitinib, a newer drug with potential benefits for lupus patients. Additionally, voclosporin—an immunosuppressant—has also emerged as a treatment option worthy of investigation. These innovative therapies offer hope for individuals living with lupus and may pave the way for improved management of this challenging condition.

What are the most recent clinical trials for lupus?

Exciting advancements in lupus research offer hope for improved treatment options. Recent clinical trials have explored various therapeutic approaches to tackle this complex autoimmune disease. In one study, BMS-986326 Dose 1 IV was investigated in Phase 1, showing promise as a potential treatment option. Another trial focused on Imvotamab (Dose Escalation), aiming to evaluate its efficacy and safety profile in lupus patients. Additionally, the effectiveness of the Herpes Zoster Subunit (HZ/su) Vaccine is being examined in Phase 4 to provide valuable insights into its use for individuals with lupus. Furthermore, Study 3 examines Upadacitinib Dose A's impact on lupus patients and holds potential as an innovative therapy option. These ongoing efforts signal progress in understanding and addressing lupus, offering renewed hope for those affected by this condition.

What lupus clinical trials were recently completed?

Recently completed clinical trials in the field of lupus have shown promising advancements in our understanding and treatment of this complex autoimmune disease. Notably, a trial sponsored by GlaxoSmithKline investigating Anifrolumab reached its completion, offering potential new options for patients. Additionally, a study led by Pfizer explored the efficacy of PF-04965842 as a therapeutic approach for lupus patients. These recent milestones highlight the ongoing efforts to improve outcomes and quality of life for individuals battling with lupus.